PAREXEL International to Present at JP Morgan Healthcare Conference
BOSTON, December 20, 2016 – PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Tuesday, January 10, 2017, in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 4:00 p.m. PT.
A live webcast of the presentation will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website for 90 days after the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51 countries around the world, and had approximately 18,750 employees in the first quarter. For more information about PAREXEL International visit www.PAREXEL.com.
Tel.: + 1-781-434-4753 or +1-781-434-8465
Tel.: +1 781-434-4019